Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
It should be used with caution in patients with a history of pancreatitis and is not recommended for use in pregnant or breastfeeding individuals
Weight loss results are not guaranteed, and some patients may experience minimal or no weight loss despite treatment compliance
Obesity and Weight Studies: Published Phase 2 data (NEJM, 2023) showed up to 24.2% mean body weight reduction at 48 weeks
Dosing strategies are individualized and typically begin at lower levels to allow the body to adjust
They lead to countless health issues
use within 12 weeks Do not refreeze reconstituted solution Allow vial to reach room temperature before opening Experimental Study Period View Certificate of Analysis View Certificate of Analysis Each batch of Retatrutide is independently tested by third-party laboratories
US$ 23.69
US$ 23.68
US$ 22.95
US$ 28.51
US$ 20.56
